ArticleScientific reports2026
Construction of a diagnostic model for preeclampsia based on differentially expressed lactylation-related genes and the immune infiltration analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Construction of a prediction model for retinopathy of prematurity based on placenta-derived genes and clinical variables.Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Preeclampsia is a complex pregnancy complication marked by hypertension and organ dysfunction, posing considerable risks to maternal and fetal health. This study aimed to explore the role of lactylation, a posttranslational modification associated with multiple disease processes, in the pathophysiology of preeclampsia. Comprehensive bioinformatics analyses identified 99 differentially expressed genes (DEGs), among which two lactylation-related DEGs (LRDEGs)-EAF1 and PFKP were significantly up-regulated in preeclampsia. Pathway enrichment analysis revealed that these LRDEGs were strongly associated with the Glycolysis/Gluconeogenesis pathway. A logistic regression model based on the LRDEGs achieved 81.7% accuracy in predicting preeclampsia, validated on the GSE54618 dataset, which achieved 91% accuracy. Immune cell infiltration analysis using CIBERSORT revealed significant differences between the preeclampsia and control cohorts. Additionally, nonnegative matrix factorization classified preeclampsia samples into two subtypes, with distinct immune infiltration profiles. Single-cell RNA sequencing analysis further revealed cell-type-specific expression of the identified diagnostic genes, highlighting heterogeneity within the placental microenvironment. The expression levels of EAF1 and PFKP were significantly increased in placental tissues from individuals with preeclampsia. Collectively, these results suggest that EAF1 and PFKP may represent potential diagnostic biomarkers for preeclampsia and may influence its onset and progression through the Glycolysis/Gluconeogenesis pathway in specific cell types.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.